Targeting the aryl hydrocarbon receptor by gut phenolic metabolites
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | , , , |
Tipo de documento: | Outros |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10362/150335 |
Resumo: | Funding Information: Several clinical trials support that the specific CD exclusion diet and the UC exclusion diet are well-established procedures to achieve remission in those patients [166]. Besides, carbohydrate diet patterns have been shown to help clinical remission in paediatric patients with CD [167,168]. However, these diets are very restrictive diets depriving people of a large number of foods. The Mediterranean diet has gained popularity to prevent and/or treat IBD due to its potential in decreasing inflammatory markers and mortality in IBD patients [169,170]. Regular consumption of a Mediterranean diet in healthy people decreases the risk of developing IBD associated with specific gut microbiome regulation as well as a reduction in gut inflammatory markers (e.g., calprotectin) [171]. The beneficial effects of long-lasting adherence to the Mediterranean diet have been attributed to specific components like (poly)phenols [172], which are very abundant in this diet and are associated with immunomodulatory properties and a reduced incidence of inflammation.This work was supported by the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme under grant agreement No 804229. iNOVA4Health Research Unit (LISBOA-01-0145-FEDER-007344), which is co-funded by Fundação para a Ciência e Tecnologia (FCT)/Ministério da Ciência e do Ensino Superior, through national funds, and by FEDER under the PT2020 Partnership Agreement, is acknowledged (UIDB/04462/2020 and UIDP/04462/2020). Y. Lian and P. Moura-Alves acknowledge the support of the Ludwig Institute for Cancer Research- Core Award, and P. Moura-Alves the H2020-WIDESPREAD-2018-951921- ImmunoHUB. Authors would like to acknowledge FCT for financial support of C. J. G. Pinto (2022.11465. BD). Funding Information: This work was supported by the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme under grant agreement No 804229 . iNOVA4Health Research Unit ( LISBOA-01-0145-FEDER-007344 ), which is co-funded by Fundação para a Ciência e Tecnologia (FCT) / Ministério da Ciência e do Ensino Superior , through national funds, and by FEDER under the PT2020 Partnership Agreement, is acknowledged ( UIDB/04462/2020 and UIDP/04462/2020 ). Y. Lian and P. Moura-Alves acknowledge the support of the Ludwig Institute for Cancer Research- Core Award , and P. Moura-Alves the H2020-WIDESPREAD-2018-951921- ImmunoHUB . Authors would like to acknowledge FCT for financial support of C. J. G. Pinto ( 2022.11465 . BD). Publisher Copyright: © 2023 The Authors |
id |
RCAP_1b85e1670fd97239878ec936713e624d |
---|---|
oai_identifier_str |
oai:run.unl.pt:10362/150335 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Targeting the aryl hydrocarbon receptor by gut phenolic metabolitesA strategy towards gut inflammationAHRDietary (poly)phenolsInflammatory bowel diseaseMicrobiotaOrganic ChemistryClinical BiochemistryFunding Information: Several clinical trials support that the specific CD exclusion diet and the UC exclusion diet are well-established procedures to achieve remission in those patients [166]. Besides, carbohydrate diet patterns have been shown to help clinical remission in paediatric patients with CD [167,168]. However, these diets are very restrictive diets depriving people of a large number of foods. The Mediterranean diet has gained popularity to prevent and/or treat IBD due to its potential in decreasing inflammatory markers and mortality in IBD patients [169,170]. Regular consumption of a Mediterranean diet in healthy people decreases the risk of developing IBD associated with specific gut microbiome regulation as well as a reduction in gut inflammatory markers (e.g., calprotectin) [171]. The beneficial effects of long-lasting adherence to the Mediterranean diet have been attributed to specific components like (poly)phenols [172], which are very abundant in this diet and are associated with immunomodulatory properties and a reduced incidence of inflammation.This work was supported by the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme under grant agreement No 804229. iNOVA4Health Research Unit (LISBOA-01-0145-FEDER-007344), which is co-funded by Fundação para a Ciência e Tecnologia (FCT)/Ministério da Ciência e do Ensino Superior, through national funds, and by FEDER under the PT2020 Partnership Agreement, is acknowledged (UIDB/04462/2020 and UIDP/04462/2020). Y. Lian and P. Moura-Alves acknowledge the support of the Ludwig Institute for Cancer Research- Core Award, and P. Moura-Alves the H2020-WIDESPREAD-2018-951921- ImmunoHUB. Authors would like to acknowledge FCT for financial support of C. J. G. Pinto (2022.11465. BD). Funding Information: This work was supported by the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme under grant agreement No 804229 . iNOVA4Health Research Unit ( LISBOA-01-0145-FEDER-007344 ), which is co-funded by Fundação para a Ciência e Tecnologia (FCT) / Ministério da Ciência e do Ensino Superior , through national funds, and by FEDER under the PT2020 Partnership Agreement, is acknowledged ( UIDB/04462/2020 and UIDP/04462/2020 ). Y. Lian and P. Moura-Alves acknowledge the support of the Ludwig Institute for Cancer Research- Core Award , and P. Moura-Alves the H2020-WIDESPREAD-2018-951921- ImmunoHUB . Authors would like to acknowledge FCT for financial support of C. J. G. Pinto ( 2022.11465 . BD). Publisher Copyright: © 2023 The AuthorsThe Aryl Hydrocarbon Receptor (AHR) is a ligand-dependent transcription factor able to control complex transcriptional processes in several cell types, which has been correlated with various diseases, including inflammatory bowel diseases (IBD). Numerous studies have described different compounds as ligands of this receptor, like xenobiotics, natural compounds, and several host-derived metabolites. Dietary (poly)phenols have been studied regarding their pleiotropic activities (e.g., neuroprotective and anti-inflammatory), but their AHR modulatory capabilities have also been considered. However, dietary (poly)phenols are submitted to extensive metabolism in the gut (e.g., gut microbiota). Thus, the resulting gut phenolic metabolites could be key players modulating AHR since they are the ones that reach the cells and may exert effects on the AHR throughout the gut and other organs. This review aims at a comprehensive search for the most abundant gut phenolic metabolites detected and quantified in humans to understand how many have been described as AHR modulators and what could be their impact on inflammatory gut processes. Even though several phenolic compounds have been studied regarding their anti-inflammatory capacities, only 1 gut phenolic metabolite, described as AHR modulator, has been evaluated on intestinal inflammatory models. Searching for AHR ligands could be a novel strategy against IBD.iNOVA4Health - pólo NMSNOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)RUNPinto, Catarina J.G.Ávila-Gálvez, María ÁngelesLian, YilongMoura-Alves, PedroNunes dos Santos, Cláudia2023-03-10T22:52:02Z2023-052023-05-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/otherapplication/pdfhttp://hdl.handle.net/10362/150335eng2213-2317PURE: 54506027https://doi.org/10.1016/j.redox.2023.102622info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-05-22T18:09:49Zoai:run.unl.pt:10362/150335Portal AgregadorONGhttps://www.rcaap.pt/oai/openairemluisa.alvim@gmail.comopendoar:71602024-05-22T18:09:49Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Targeting the aryl hydrocarbon receptor by gut phenolic metabolites A strategy towards gut inflammation |
title |
Targeting the aryl hydrocarbon receptor by gut phenolic metabolites |
spellingShingle |
Targeting the aryl hydrocarbon receptor by gut phenolic metabolites Pinto, Catarina J.G. AHR Dietary (poly)phenols Inflammatory bowel disease Microbiota Organic Chemistry Clinical Biochemistry |
title_short |
Targeting the aryl hydrocarbon receptor by gut phenolic metabolites |
title_full |
Targeting the aryl hydrocarbon receptor by gut phenolic metabolites |
title_fullStr |
Targeting the aryl hydrocarbon receptor by gut phenolic metabolites |
title_full_unstemmed |
Targeting the aryl hydrocarbon receptor by gut phenolic metabolites |
title_sort |
Targeting the aryl hydrocarbon receptor by gut phenolic metabolites |
author |
Pinto, Catarina J.G. |
author_facet |
Pinto, Catarina J.G. Ávila-Gálvez, María Ángeles Lian, Yilong Moura-Alves, Pedro Nunes dos Santos, Cláudia |
author_role |
author |
author2 |
Ávila-Gálvez, María Ángeles Lian, Yilong Moura-Alves, Pedro Nunes dos Santos, Cláudia |
author2_role |
author author author author |
dc.contributor.none.fl_str_mv |
iNOVA4Health - pólo NMS NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM) RUN |
dc.contributor.author.fl_str_mv |
Pinto, Catarina J.G. Ávila-Gálvez, María Ángeles Lian, Yilong Moura-Alves, Pedro Nunes dos Santos, Cláudia |
dc.subject.por.fl_str_mv |
AHR Dietary (poly)phenols Inflammatory bowel disease Microbiota Organic Chemistry Clinical Biochemistry |
topic |
AHR Dietary (poly)phenols Inflammatory bowel disease Microbiota Organic Chemistry Clinical Biochemistry |
description |
Funding Information: Several clinical trials support that the specific CD exclusion diet and the UC exclusion diet are well-established procedures to achieve remission in those patients [166]. Besides, carbohydrate diet patterns have been shown to help clinical remission in paediatric patients with CD [167,168]. However, these diets are very restrictive diets depriving people of a large number of foods. The Mediterranean diet has gained popularity to prevent and/or treat IBD due to its potential in decreasing inflammatory markers and mortality in IBD patients [169,170]. Regular consumption of a Mediterranean diet in healthy people decreases the risk of developing IBD associated with specific gut microbiome regulation as well as a reduction in gut inflammatory markers (e.g., calprotectin) [171]. The beneficial effects of long-lasting adherence to the Mediterranean diet have been attributed to specific components like (poly)phenols [172], which are very abundant in this diet and are associated with immunomodulatory properties and a reduced incidence of inflammation.This work was supported by the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme under grant agreement No 804229. iNOVA4Health Research Unit (LISBOA-01-0145-FEDER-007344), which is co-funded by Fundação para a Ciência e Tecnologia (FCT)/Ministério da Ciência e do Ensino Superior, through national funds, and by FEDER under the PT2020 Partnership Agreement, is acknowledged (UIDB/04462/2020 and UIDP/04462/2020). Y. Lian and P. Moura-Alves acknowledge the support of the Ludwig Institute for Cancer Research- Core Award, and P. Moura-Alves the H2020-WIDESPREAD-2018-951921- ImmunoHUB. Authors would like to acknowledge FCT for financial support of C. J. G. Pinto (2022.11465. BD). Funding Information: This work was supported by the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme under grant agreement No 804229 . iNOVA4Health Research Unit ( LISBOA-01-0145-FEDER-007344 ), which is co-funded by Fundação para a Ciência e Tecnologia (FCT) / Ministério da Ciência e do Ensino Superior , through national funds, and by FEDER under the PT2020 Partnership Agreement, is acknowledged ( UIDB/04462/2020 and UIDP/04462/2020 ). Y. Lian and P. Moura-Alves acknowledge the support of the Ludwig Institute for Cancer Research- Core Award , and P. Moura-Alves the H2020-WIDESPREAD-2018-951921- ImmunoHUB . Authors would like to acknowledge FCT for financial support of C. J. G. Pinto ( 2022.11465 . BD). Publisher Copyright: © 2023 The Authors |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-03-10T22:52:02Z 2023-05 2023-05-01T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/other |
format |
other |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10362/150335 |
url |
http://hdl.handle.net/10362/150335 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
2213-2317 PURE: 54506027 https://doi.org/10.1016/j.redox.2023.102622 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
mluisa.alvim@gmail.com |
_version_ |
1817545921290829824 |